Please ensure Javascript is enabled for purposes of website accessibility

Why Tilray, Canopy Growth, and Hexo Stock Rose Today

By Howard Smith – Sep 2, 2021 at 4:26PM

Key Points

  • The deadline for public comment on a proposed legalization bill just passed, and proponents had plenty to say.
  • Canadian cannabis companies have been preparing for the opening of the U.S. market with acquisitions and investments.

Motley Fool Issues Rare “All In” Buy Alert

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More

Cannabis companies continue to consolidate and make plans for potential legalization in the U.S.

What happened

Canadian cannabis company stocks have taken a hit over the last six months, so it's not surprising to see an occasional bullish swing in shares. Today is one of those days. After each jumped about 5% earlier today, as of 3 p.m. EDT shares of Tilray (TLRY 1.85%), Canopy Growth (CGC 4.57%), and Hexo (HEXO -1.35%) were 2%, 3.5%, and 1.7% higher, respectively. 

So what

These names broadly trade on two types of news, beyond individual financial updates. The industry continues to consolidate, and acquisition news gets significant interest from investors. Secondly, a sway in any direction related to political attempts to broaden legalization in the U.S. is another significant driver. On that front, yesterday was the deadline for public comment on the federal marijuana legalization bill Sen. Chuck Schumer and several of his colleagues have drafted and sponsored. And it seems that supporters have been flooding the political leaders with comments. 

Drawing of U.S. flag surrounded by marijuana leaves.

Image source: Getty Images.

Now what

The Cannabis Administration and Opportunity Act proposed by Schumer and two other Democratic senators in early July seeks to legalize pot at the federal level, and remove marijuana from the Controlled Substances Act. Senators got plenty of input leading up to the Sept. 1 deadline for comment, according to trade publication Marijuana Moment

The feedback came largely from pro-reform groups, though there was reportedly also response from prohibitionist groups seeking to address their concerns on the topic of legalization

The U.S. Cannabis Council expressed its support of the sponsor's goals, but noted that the Treasury Department's Alcohol and Tobacco Tax and Trade Bureau should be responsible for regulating the cannabis industry. The American Trade Association for Cannabis and Hemp stressed it supported "the need for increased recognition and understanding of the interaction with existing state-level regulatory frameworks, the treatment of hemp and CBD, and taxation policy."

The bottom line for Canadian cannabis companies is that if U.S. legalization occurs at the federal level, those companies stand to benefit. To that end, several have made inroads in the U.S. to be prepared for that potential outcome. Canopy Growth has a large investor in Constellation Brands, giving it a distribution network to lean on. Tilray has also made investments in the U.S., most recently with American retailer MedMen through convertible notes that would allow Tilray to obtain a majority position in the future. 

Many investments in Canadian cannabis companies are made counting on the potential opening of the huge American market. States have been progressing in that direction, and with a federal bill in draft form now too, proponents are making their voices heard.

Howard Smith owns shares of Tilray, Inc. The Motley Fool owns shares of and recommends Constellation Brands. The Motley Fool recommends HEXO Corp. The Motley Fool has a disclosure policy.

Invest Smarter with The Motley Fool

Join Over 1 Million Premium Members Receiving…

  • New Stock Picks Each Month
  • Detailed Analysis of Companies
  • Model Portfolios
  • Live Streaming During Market Hours
  • And Much More
Get Started Now

Stocks Mentioned

Tilray, Inc. Stock Quote
Tilray, Inc.
$3.85 (1.85%) $0.07
Canopy Growth Corp. Stock Quote
Canopy Growth Corp.
$3.66 (4.57%) $0.16
HEXO Corp. Stock Quote
HEXO Corp.
$0.17 (-1.35%) $0.00

*Average returns of all recommendations since inception. Cost basis and return based on previous market day close.

Related Articles

Motley Fool Returns

Motley Fool Stock Advisor

Market-beating stocks from our award-winning analyst team.

Stock Advisor Returns
S&P 500 Returns

Calculated by average return of all stock recommendations since inception of the Stock Advisor service in February of 2002. Returns as of 11/27/2022.

Discounted offers are only available to new members. Stock Advisor list price is $199 per year.

Premium Investing Services

Invest better with The Motley Fool. Get stock recommendations, portfolio guidance, and more from The Motley Fool's premium services.